E&G Advisors’s Bristol-Myers Squibb BMY Stock Holding History

E&G Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Buy	4,351 +100	+2%	+$5.74K	0.05%	219
2026 Q1	$258K	Hold	4,251	–	–	0.06%	201
2025 Q4	$230K	Buy	+4,251	New	+$205K	0.05%	207
2025 Q2	–	Sell	-4,251	Closed	-$259K	–	212
2025 Q1	$259K	Hold	4,251	–	–	0.07%	181
2024 Q4	$241K	Sell	4,251 -1,200	-22%	-$67K	0.07%	186
2024 Q3	$283K	Sell	5,451 -400	-7%	-$18.8K	0.08%	172
2024 Q2	$245K	Buy	5,851 +300	+5%	+$13.4K	0.07%	186
2024 Q1	$302K	Buy	5,551 +301	+6%	+$15.3K	0.09%	152
2023 Q4	$270K	Sell	5,250 -600	-10%	-$31.5K	0.1%	160
2023 Q3	$340K	Sell	5,850 -50	-0.8%	-$3.06K	0.12%	141
2023 Q2	$377K	Hold	5,900	–	–	0.13%	138
2023 Q1	$409K	Buy	5,900 +100	+2%	+$7.05K	0.15%	130
2022 Q4	$417K	Buy	5,800 +200	+4%	+$15.1K	0.16%	131
2022 Q3	$398K	Sell	5,600 -70	-1%	-$5.08K	0.15%	134
2022 Q2	$437K	Sell	5,670 -30	-0.5%	-$2.29K	0.15%	131
2022 Q1	$416K	Sell	5,700 -800	-12%	-$53.7K	0.11%	150
2021 Q4	$405K	Hold	6,500	–	–	0.1%	153
2021 Q3	$385K	Buy	+6,500	New	+$428K	0.1%	150
2021 Q2	–	Sell	-6,700	Closed	-$437K	–	140
2021 Q1	$423K	Hold	6,700	–	–	0.12%	138
2020 Q4	$416K	Hold	6,700	–	–	0.13%	130
2020 Q3	$404K	Hold	6,700	–	–	0.14%	120
2020 Q2	$394K	Hold	6,700	–	–	0.15%	118
2020 Q1	$373K	Buy	6,700 +800	+14%	+$48.9K	0.18%	103
2019 Q4	$379K	Sell	5,900 -2,000	-25%	-$115K	0.14%	139
2019 Q3	$401K	Sell	7,900 -200	-2%	-$9.4K	0.16%	126
2019 Q2	$367K	Buy	8,100 +600	+8%	+$27.9K	0.16%	131
2019 Q1	$358K	Sell	7,500 -3,300	-31%	-$164K	0.16%	135
2018 Q4	$561K	Buy	10,800 +1,100	+11%	+$59.1K	0.25%	109
2018 Q3	$602K	Buy	9,700 +1,900	+24%	+$113K	0.23%	114
2018 Q2	$432K	Buy	7,800 +700	+10%	+$37.8K	0.18%	130
2018 Q1	$449K	Sell	7,100 -716	-9%	-$46.1K	0.19%	114
2017 Q4	$479K	Buy	7,816 +1,500	+24%	+$93.8K	0.2%	106
2017 Q3	$403K	Buy	6,316 +1,200	+23%	+$70.1K	0.18%	114
2017 Q2	$285K	Buy	+5,116	New	+$278K	0.14%	133
2016 Q2	–	Sell	-3,816	Closed	-$244K	–	105
2016 Q1	$244K	Hold	3,816	–	–	0.16%	85
2015 Q4	$263K	Hold	3,816	–	–	0.16%	83
2015 Q3	$226K	Hold	3,816	–	–	0.14%	84
2015 Q2	$254K	Hold	3,816	–	–	0.15%	82
2015 Q1	$246K	Hold	3,816	–	–	0.15%	85
2014 Q4	$225K	Buy	+3,816	New	+$215K	0.15%	88
2014 Q1	–	Sell	-3,816	Closed	-$203K	–	85
2013 Q4	$203K	Buy	+3,816	New	+$194K	0.19%	76

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

E&G Advisors's BMY Position: Q2 2026 in Review

E&G Advisors increased its Bristol-Myers Squibb (BMY) stake by 2.4% in Q2 2026, buying an estimated $5.74K and bringing the position to 4,351 shares worth $251K. The position accounts for 0.05% of the portfolio, ranked #219.

E&G Advisors first reported a position in BMY in Q4 2013 and has held it in 41 quarters since. The position peaked at $602K in Q3 2018. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

E&G Advisors held 4,351 shares of Bristol-Myers Squibb worth $251K as of Q2 2026.
E&G Advisors bought 100 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.74K.
Bristol-Myers Squibb made up 0.05% of E&G Advisors's portfolio in Q2 2026, its #219 holding.
E&G Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 41 quarters since.
E&G Advisors's Bristol-Myers Squibb position peaked at $602K in Q3 2018.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on E&G Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.